Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Diethanolamine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BTN3A1 | O00481 | 2/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL89762 | 0.84 | BTN3A1 (0.38) | BTN3A1 | |
| SCHEMBL11882140 | 0.79 | LPAR3 (0.32) | BTN3A1 | |
| Ammonia Solution, Strong SCHEMBL8940797 | 0.70 | LPAR3 (0.34) | BTN3A1 | |
| SCHEMBL4564693 | 0.69 | — | — | |
| SCHEMBL4564135 | 0.69 | — | — | |
| Diethanolamine SCHEMBL1831509 | 0.68 | S1PR2 (0.34) | — | |
| Diethanolamine SCHEMBL1833785 | 0.68 | S1PR2 (0.34) | — | |
| Diethanolamine SCHEMBL5026621 | 0.68 | S1PR2 (0.34) | — | |
| Diethanolamine SCHEMBL75329 | 0.68 | S1PR2 (0.34) | — | |
| SCHEMBL89528 | 0.67 | FNTA (0.31) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2084167-B1 | FLUOROALKYL PHOSPHATE COMPOSITIONS | DU PONT (US) | 2013-07-31 | — | — | EP | disclosed |
| US-8129568-B2 | Fluoroalkyl phosphate compositions | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 2012-03-06 | — | — | US | disclosed |
| US-8049040-B2 | Ethylene-tetrafluoroethylene phosphate composition | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 2011-11-01 | — | — | US | disclosed |
| US-20110200815-A1 | FLUOROALKYL PHOSPHATE COMPOSITIONS | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2011-08-18 | — | — | US | disclosed |
| US-7951975-B2 | Fluoroalkyl phosphate compositions | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 2011-05-31 | — | — | US | disclosed |
| EP-2293876-A1 | ETHYLENE-TETRAFLUOROETHYLENE PHOSPHATE COMPOSITION | E. I. du Pont de Nemours and Company (US) | 2011-03-16 | — | — | EP | disclosed |
| WO-2009143088-A1 | ETHYLENE-TETRAFLUOROETHYLENE PHOSPHATE COMPOSITION | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2009-11-26 | — | — | WO | disclosed |
| US-20090286885-A1 | Ethylene-tetrafluoroethylene phosphate composition | E.I. DU PONT DE NEMUOURS AND COMPANY (US) | 2009-11-19 | — | — | US | disclosed |
| EP-2084167-A1 | FLUOROALKYL PHOSPHATE COMPOSITIONS | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 2009-08-05 | — | — | EP | disclosed |
| US-20090087670-A1 | FLUOROALKYL PHOSPHATE COMPOSITIONS | E. I. DU PONT DE NEMOURS AND COMPANY | 2009-04-02 | — | — | US | disclosed |
| WO-2008060352-A1 | FLUOROALKYL PHOSPHATE COMPOSITIONS | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2008-05-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090286885-A1 | Ethylene-tetrafluoroethylene phosphate composition | TWF2, CLCN2, KCNN2 | BTN3A1 2946/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.